−45.3
Vistagen Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
Change from FY22 to FY26
millions USD
FY22:
FY23:
−49.7
FY24:
−25.8
FY25:
−42.1
FY26:
−66.4
Change from FY22 to FY26
millions USD
FY22:
−0.20
FY23:
−0.74
FY24:
−0.06
FY25:
−13.1
FY26:
−0.88
Change from FY22 to FY26
millions USD
FY22:
10.5
FY23:
−1.04
FY24:
128
FY25:
3.21
FY26:
31.0
millions USD
FY22:
−35.0
FY23:
−51.5
FY24:
103
FY25:
−52.0
FY26:
−36.3
(positive)
Change from FY22 to FY24
millions USD
FY22:
−45.5
FY23:
−50.2
FY24:
−25.8
FY25:
–
FY26:
–
All amounts in millions USD